•
Sep 30, 2024

Cardlytics Q3 2024 Earnings Report

Cardlytics' third quarter results surpassed guidance, demonstrating a focus on addressing short-term challenges amidst an ongoing business transformation.

Key Takeaways

Cardlytics reported a revenue of $67.1 million, a 15% decrease year-over-year, and a net loss of $145.2 million, or $2.90 per diluted share, compared to a net loss of $24.0 million, or $0.63 per diluted share in the third quarter of 2023. The company's MAUs increased by 2% year-over-year to 166.4 million, while ARPU decreased to $0.40 from $0.49 in the third quarter of 2023.

Revenue was $67.1 million, a decrease of 15% year-over-year, or 13% excluding Entertainment.

Billings were $112.0 million, a decrease of 4% year-over-year, or 2% excluding Entertainment.

Net Loss was $145.2 million, or $2.90 per diluted share.

Cardlytics MAUs were 166.4 million, an increase of 2% year-over-year.

Total Revenue
$67.1M
Previous year: $79M
-15.1%
EPS
-$0.15
Previous year: -$0.01
+1400.0%
Monthly Active Users
166.4M
Previous year: 162.5M
+2.4%
Average Revenue per User
$0.4
Previous year: $0.49
-18.4%
Gross Profit
$28.6M
Previous year: $35.8M
-20.4%
Cash and Equivalents
$67M
Previous year: $90.1M
-25.6%
Free Cash Flow
-$3.9M
Previous year: $1.14M
-441.2%
Total Assets
$399M
Previous year: $635M
-37.1%

Cardlytics

Cardlytics

Forward Guidance

Cardlytics anticipates Billings, Revenue, Adjusted Contribution and Adjusted EBITDA to be in the following ranges (in millions, except for percentage change rates):

Positive Outlook

  • Billings are expected to be between $102.0 million and $108.0 million.
  • Revenue is projected to be between $62.0 million and $67.0 million.
  • Adjusted Contribution is anticipated to be between $33.0 million and $36.0 million.
  • Adjusted EBITDA is forecasted to be between $(5.0) million and $(1.0) million.

Challenges Ahead

  • Billings are expected to decrease by 23% - 18% year-over-year.
  • Revenue is projected to decrease by 30% - 25% year-over-year.
  • Adjusted Contribution is anticipated to decrease by 30% - 24% year-over-year.
  • Adjusted EBITDA is forecasted to decrease by $15.0 million - $11.0 million year-over-year.